Abstract
Incidence of neuroendocrine tumors (NETs) is increasing, including those of the gastroenteropancreatic tract. A proper understanding of the management of this disease has become necessary for the general surgeon. This article addresses current guidelines for diagnosis and localization of NETs, including somatostatin receptor PET. Updated treatment and outcomes of NETs by primary tumor site are discussed as well as those metastatic to the liver.
Original language | English (US) |
---|---|
Pages (from-to) | 635-648 |
Number of pages | 14 |
Journal | Surgical Clinics of North America |
Volume | 100 |
Issue number | 3 |
DOIs | |
State | Published - Jun 2020 |
Externally published | Yes |
Keywords
- Appendix
- Carcinoid
- Liver metastases
- Neuroendocrine
- Pancreas
- Small intestine
ASJC Scopus subject areas
- Surgery